Ercros, S.A. (FRA:CRS1)

Market Cap	312.25M +16.2%
Revenue (ttm)	628.69M -5.9%
Net Income	-53.59M
EPS	-0.59
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	512
Open	3.405
Previous Close	3.365
Day's Range	3.405 - 3.405
52-Week Range	2.210 - 3.490
Beta	n/a
RSI	53.62
Earnings Date	Feb 27, 2026

About Ercros

Ercros, S.A., together with its subsidiaries, manufactures and sells chemical and pharmaceutical products in Spain and internationally. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmaceuticals. The company offers ammonia, caustic soda and potash, chlorine chloroisocyanurates, dichloroethane, ercrosbio, hydrochloric acid, hydrogen peroxide, polyvinyl chloride, potassium carbonate, PVC compounds, sodium chlorate, sodium chlorite, sodium hypochlorite, sulfuric acid, and vinyl chloride. It also provides ...

• Industry: Industrial Inorganic Chemicals
• Founded: 1817
• Employees: 1,329
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: CRS1

Financial Performance

In 2025, Ercros's revenue was 628.69 million, a decrease of -5.92% compared to the previous year's 668.22 million. Losses were -53.59 million, 359.7% more than in 2024.